APA

Errington F., Willmore E., Leontiou C., Tilby M. J. & Austin C. A. (20040309). Differences in the longevity of topo IIalpha and topo IIbeta drug-stabilized cleavable complexes and the relationship to drug sensitivity. : Cancer chemotherapy and pharmacology.

Chicago

Errington Fiona, Willmore Elaine, Leontiou Chrysoula, Tilby Michael J and Austin Caroline A. 20040309. Differences in the longevity of topo IIalpha and topo IIbeta drug-stabilized cleavable complexes and the relationship to drug sensitivity. : Cancer chemotherapy and pharmacology.

Harvard

Errington F., Willmore E., Leontiou C., Tilby M. J. and Austin C. A. (20040309). Differences in the longevity of topo IIalpha and topo IIbeta drug-stabilized cleavable complexes and the relationship to drug sensitivity. : Cancer chemotherapy and pharmacology.

MLA

Errington Fiona, Willmore Elaine, Leontiou Chrysoula, Tilby Michael J and Austin Caroline A. Differences in the longevity of topo IIalpha and topo IIbeta drug-stabilized cleavable complexes and the relationship to drug sensitivity. : Cancer chemotherapy and pharmacology. 20040309.